MD Anderson
Myriad Genetics, MD Anderson Partner to Study Clinical Utility of MRD Assay
Under the five-year agreement, the partners will assess the clinical utility of Myriad's Precise MRD test in breast, gastrointestinal, genitourinary, and gynecological cancers.
People in the News at the Chinese University of Hong Kong, Freenome, Burning Rock, Accellix, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
MD Anderson Nabs $3M in State Funding to Establish Spatial Genomics Core
The award is part of a $21.4 million grant MD Anderson received from the Cancer Prevention and Research Institute of Texas to support cancer research.
The research team developed a DNA methylation-based classifier to distinguish between small cell lung cancer subtypes.
Written by early OGM adopters, the framework describes best practices for the technology's clinical implementation for hematological malignancies.
Jun 15, 2022
Mar 28, 2022
Jun 29, 2021
Nov 11, 2020
Oct 12, 2020